The activation of the LYN kinase plays a role in some cases of imatinib resistance that are not caused by mutations in the amplification of the BCR-ABL gene in patients with chronic myelogenous leukemia. Medscape Medical News
In this engaging Spotlight, renowned experts discuss the most up-to-date information on the treatment of patients with myelodysplastic syndrome. Medscape Hematology-Oncology
In this Expert Interview from ASCO 2008, Dr. Robert Motzer discusses the evolving role of mTOR inhibition in the treatment of renal cell carcinoma, with a focus on the newest agent in the class. Medscape Hematology-Oncology
Although nerve-sparing technique has improved outcomes, erectile dysfunction is still common after radical prostatectomy. John Mulhall reviews the latest findings on post-RP penile rehabilitation. Medscape Urology
In a startling recommendation, the European Medicines Agency is urging oncologists to favor transfusions over erythropoiesis-stimulating agents. Medscape Medical News
The CTC-chip allows for molecular analysis of circulating tumor cells in lung cancer patients, and thus provides the ability to monitor changes in epithelial tumor genotypes during treatment. Medscape Medical News
FLT-PET imaging may be able to determine treatment response among adult leukemia patients after only 1 day of chemotherapy, which can improve disease management and spare patients from ineffective chemotherapy Medscape Medical News
